Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype
-
Published:2023-12-08
Issue:
Volume:
Page:
-
ISSN:0300-8126
-
Container-title:Infection
-
language:en
-
Short-container-title:Infection
Author:
Wolters ManuelORCID, Berinson BenjaminORCID, Degel-Brossmann Nicole, Hoffmann Armin, Bluszis Rico, Aepfelbacher Martin, Rohde HolgerORCID, Christner MartinORCID
Abstract
Abstract
Purpose
Hypertoxigenic Streptococcus pyogenes emm1 lineage M1UK has recently been associated with upsurges of invasive infections and scarlet fever in several countries, but whole-genome sequencing surveillance data of lineages circulating in Germany is lacking. In this study, we investigated recent iGAS isolates from our laboratory at a German tertiary care center for the presence of the M1UK lineage.
Methods
Whole-genome sequencing was employed to characterize a collection of 47 consecutive non-copy isolates recovered from blood cultures (21) and tissue samples (26) in our laboratory between October 2022 and April 2023.
Results
M protein gene (emm) typing distinguished 14 different emm types, with emm1 (17) being the dominant type. Single-nucleotide polymorphism (SNP) analysis confirmed the presence of all 27 SNPs characteristic for the M1UK lineage in 14 of 17 emm1 isolates.
Conclusion
This study has shown for the first time that M1UK is present in Germany and might constitute a driving force in the observed surge of GAS infections. This observation mirrors developments in the UK and other countries and underscores the importance of WGS surveillance to understand the epidemiology of GAS.
Funder
Universitätsklinikum Hamburg-Eppendorf (UKE)
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of group A streptococcus. Clin Microbiol Rev. 2014;27:264–301. 2. WHO. Increase in invasive group A streptococcal infections among children in Europe, including fatalities. WHO; 2022. 3. van der Putten BCL, Vlaminckx BJM, de Gier B, Freudenburg-de Graaf W, van Sorge NM. Group A streptococcal meningitis with the M1UK variant in the Netherlands. JAMA. 2023;329:1791–2. 4. Johannesen TB, Munkstrup C, Edslev SM, Baig S, Nielsen S, Funk T, Kristensen DK, Jacobsen LH, Ravn SF, Bindslev N, Gubbels S, Voldstedlund M, Jokelainen P, Hallstrom S, Rasmussen A, Kristinsson KG, Fuglsang-Damgaard D, Dessau RB, Olsen AB, Jensen CS, Skovby A, Ellermann-Eriksen S, Jensen TG, Dzajic E, Ostergaard C, Lomborg Andersen S, Hoffmann S, Andersen PH, Stegger M. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill. 2023. https://doi.org/10.2807/1560-7917.ES.2023.28.26.2300291. 5. Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, Ped GASNWG. Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Europe. 2023;27: 100597.
|
|